C.M. Bidwell & Associates’s Alkermes ALKS Stock Holding History
Bought
Maintained
Sold
Other funds holding ALKS
BBA
VPM
VCM
CC
C.M. Bidwell & Associates's ALKS Position: Q1 2026 in Review
C.M. Bidwell & Associates reduced its Alkermes (ALKS) stake by 25% in Q1 2026, selling an estimated $20.1K and leaving 1,981 shares worth $70K. The position accounts for 0.03% of the portfolio, ranked #196.
C.M. Bidwell & Associates first reported a position in ALKS in Q3 2023 and has held it in 5 quarters since. The position peaked at $73.6K in Q4 2025. 389 funds tracked by Wall St. Rank hold ALKS as of Q1 2026.
- C.M. Bidwell & Associates held 1,981 shares of Alkermes worth $70K as of Q1 2026.
- C.M. Bidwell & Associates sold 649 Alkermes shares in Q1 2026, an estimated $20.1K.
- Alkermes made up 0.03% of C.M. Bidwell & Associates's portfolio in Q1 2026, its #196 holding.
- C.M. Bidwell & Associates first reported a position in Alkermes in Q3 2023 and has held it in 5 quarters since.
- C.M. Bidwell & Associates's Alkermes position peaked at $73.6K in Q4 2025.
- 389 funds tracked by Wall St. Rank held Alkermes as of Q1 2026.
Based on C.M. Bidwell & Associates's 13F filing for Q1 2026, filed 15 May 2026.